Regulatory News
Monday, July 18, 2016
UPDATE 1-AstraZeneca's lung cancer drug meets main goal in late-stage trial
July 18 (Reuters) - AstraZeneca Plc said its
experimental lung cancer drug Tagrisso met its main goal in a
late-stage study.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment